IBDEI3E7 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,57047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57047,1,3,0)
 ;;=3^DM Type 2 w/ DM Dermatitis
 ;;^UTILITY(U,$J,358.3,57047,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,57047,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,57048,0)
 ;;=E11.621^^264^2849^94
 ;;^UTILITY(U,$J,358.3,57048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57048,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,57048,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,57048,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,57049,0)
 ;;=E11.622^^264^2849^99
 ;;^UTILITY(U,$J,358.3,57049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57049,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,57049,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,57049,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,57050,0)
 ;;=E11.630^^264^2849^98
 ;;^UTILITY(U,$J,358.3,57050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57050,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,57050,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,57050,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,57051,0)
 ;;=E11.641^^264^2849^96
 ;;^UTILITY(U,$J,358.3,57051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57051,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,57051,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,57051,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,57052,0)
 ;;=E11.649^^264^2849^97
 ;;^UTILITY(U,$J,358.3,57052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57052,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,57052,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,57052,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,57053,0)
 ;;=E11.65^^264^2849^95
 ;;^UTILITY(U,$J,358.3,57053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57053,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,57053,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,57053,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,57054,0)
 ;;=G56.41^^264^2849^59
 ;;^UTILITY(U,$J,358.3,57054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57054,1,3,0)
 ;;=3^Causalgia Rt Upper Limb
 ;;^UTILITY(U,$J,358.3,57054,1,4,0)
 ;;=4^G56.41
 ;;^UTILITY(U,$J,358.3,57054,2)
 ;;=^5004030
 ;;^UTILITY(U,$J,358.3,57055,0)
 ;;=G56.42^^264^2849^58
 ;;^UTILITY(U,$J,358.3,57055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57055,1,3,0)
 ;;=3^Causalgia Lt Upper Limb
 ;;^UTILITY(U,$J,358.3,57055,1,4,0)
 ;;=4^G56.42
 ;;^UTILITY(U,$J,358.3,57055,2)
 ;;=^5004031
 ;;^UTILITY(U,$J,358.3,57056,0)
 ;;=I65.21^^264^2849^124
 ;;^UTILITY(U,$J,358.3,57056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57056,1,3,0)
 ;;=3^Occlusion & Stenosis Rt Carotid Artery
 ;;^UTILITY(U,$J,358.3,57056,1,4,0)
 ;;=4^I65.21
 ;;^UTILITY(U,$J,358.3,57056,2)
 ;;=^5007360
 ;;^UTILITY(U,$J,358.3,57057,0)
 ;;=I65.22^^264^2849^123
 ;;^UTILITY(U,$J,358.3,57057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57057,1,3,0)
 ;;=3^Occlusion & Stenosis Lt Carotid Artery
 ;;^UTILITY(U,$J,358.3,57057,1,4,0)
 ;;=4^I65.22
 ;;^UTILITY(U,$J,358.3,57057,2)
 ;;=^5007361
 ;;^UTILITY(U,$J,358.3,57058,0)
 ;;=I65.23^^264^2849^122
 ;;^UTILITY(U,$J,358.3,57058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57058,1,3,0)
 ;;=3^Occlusion & Stenosis Bil Carotid Arteries
 ;;^UTILITY(U,$J,358.3,57058,1,4,0)
 ;;=4^I65.23
 ;;^UTILITY(U,$J,358.3,57058,2)
 ;;=^5007362
 ;;^UTILITY(U,$J,358.3,57059,0)
 ;;=I63.131^^264^2849^66
 ;;^UTILITY(U,$J,358.3,57059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57059,1,3,0)
 ;;=3^Cereb Infarc d/t Rt Carotid Artery Embolism
 ;;^UTILITY(U,$J,358.3,57059,1,4,0)
 ;;=4^I63.131
 ;;^UTILITY(U,$J,358.3,57059,2)
 ;;=^5007308
 ;;^UTILITY(U,$J,358.3,57060,0)
 ;;=I63.132^^264^2849^64
